Authors


Jonathan Ogurchak, PharmD

Latest:

Preparing for a Career in Specialty Pharmacy

There are a multitude of reasons why pharmacy students choose to pursue a career in specialty pharmacy.


Rubina Khan, PharmD

Latest:

Working Outside the Dispensing Box: The Roles of the Medical Information Specialist and Medical Science Liaison

As medical information specialists and medical science liaisons, pharmacists use their drug expertise and clinical skills to serve as information providers


Mary Anne Wawrzyn, RPh

Latest:

FOCUS ON THE FUTURE: COLLEGE HEALTH

Ms.Wawrzyn is the Norris Health CenterPharmacy Manager and the Introduction to the Practice of Pharmacy Course Instructor at the University of Wisconsin-Milwaukee.


HCP Live Staff

Latest:

Combination Treatment with Daclatasvir Produces Good Results in Patients with Genotype 4 Hepatitis C

SVR12 rates significantly higher in patients treated with daclatasvir/peginterferon alfa/ribavirin combination.


Deepali Dixit, PharmD, BCPS, BCCCP

Latest:

Opioid-Induced Constipation

Opioids are associated with various adverse effects, including constipation, nausea, respiratory depression, sedation, and vomiting.


Ogechukwu Okonkwo, PharmD Candidate

Latest:

Janssen Pharmaceuticals' Xarelto

The FDA approved Xarelto (rivaroxaban) for the prevention of venous thromboembolism following hip or knee replacements and for the prevention of stroke in patients with nonvalvular atrial fibrillation.


Lauren M. Green

Latest:

Relapsed Hodgkin Lymphoma Combination Shows Promise

The combination of brentuximab vedotin (Adcetris) and nivolumab (Opdivo) found to be active and safe in relapsed/refractory classical Hodgkin lymphoma.


Jennifer Whiteley, EdD

Latest:

Impact of Co-Payment Discounts on Antidepressant Medication Adherence and Costs

A unique co-payment discount program for antidepressants was associated with higher antidepressant medication adherence, lower likelihood of discontinuation, and lower healthcare costs.



Lee Feigert, PharmD, MSPBA Candidate

Latest:

Patient Satisfaction in the Specialty Pharmacy Space

As is the case with any service-driven industry, the need to continually assess end-user satisfaction is paramount.


Kristen E. Wilhite, PharmD Candidate

Latest:

Rising Insulin Prices Catch Policy Makers' Attention

Colorado legislature enacts price caps of $100 per month for products and authorizes attorney general to investigate pricing.


Corey Allikas

Latest:

OxyContin Approved for Pediatric Use

The FDA has expanded the use of the powerful painkiller oxycodone (OxyContin) for children as young as 11.


Lisa Holle, PharmD, BCOP

Latest:

Small Molecule Inhibitors for the Treatment of Chronic Lymphocytic Leukemia

Importantly, when considering the useof small molecule inhibitors, potential drug interactions must be evaluated.


Jessica E. Lendoiro, PharmD

Latest:

Perspectives From Pharmacists, Educators on the Frontlines of COVID-19 Immunizations

As a majority of advanced pharmacy practice experiences need to include direct patient care, immunizing provides students an opportunity to provide this care along with consultation around the COVID-19 vaccine and adverse effects.


Chiedozie Udeh, MBBS, MHlthEcon

Latest:

Cost-Effectiveness of Stress Ulcer Prophylaxis: Role of Proton Pump Inhibitors

Proton pump inhibitors are cost-effective options for stress ulcer prophylaxis.


Jan E. Berger, MD, MJ-Editor-in-Chief

Latest:

Opportunity and Challenges in Treating Neurologic Conditions

This issue of The American Journal of Pharmacy Benefts includes several articles about neurologic conditions and the medications used to treat them. We chose to focus on this area for 2 reasons.


Madeleine King, Erinne Weber,

Latest:

More Medications Means Changes to HIV Treatment Guidelines

The HIV treatment update includes more considerations for coinfected patients and pregnant women than the previously published 2011 guidelines.


Evelyn Sarnes, PharmD, MPH

Latest:

Cost-Effectiveness of Fingolimod in Treating Patients With Relapsing-Remitting Multiple Sclerosis

Fingolimod, a first-line, once-daily oral disease-modifying therapy for relapsing-remitting multiple sclerosis, has the lowest cost per relapse avoided compared with other first-line agents.


Sandra Fyfe, MA

Latest:

Complementary Therapies and Patients With Cancer: Pearls for Avoiding Adverse Events

Complementary therapies, such as supplements or aromatherapy, have the potential to benefit patients with cancer, but can also trigger adverse events when they interact with oncology medications.


Curtis E. Haas, PharmD, FCCP, Pharmacy Times® Health-System Edition Editor in Chief

Latest:

Most Favored Nation Pricing Is More Political Whitewash

Health systems get just 36 days to make major administrative, information system, and operational changes amid the pandemic’s peak.


Lori T. Armistead, PharmD

Latest:

Withdrawal of Inhaled Corticosteroids in Patients with Stable Chronic Obstructive Pulmonary Disease

COPD is the fourth leading cause of death in the United States, contributing to more than 120,000 deaths each year.


Iris Rosendahl

Latest:

WIDE-RANGING OPPORTUNITIES AT CARDINAL HEALTH

Ms. Rosendahl is a freelance writer based in Fort Lee, NJ.


Staley Lawes, PharmD, BCPS, FISMP

Latest:

Hyperkalemia: Caught in a Bind?

Hyperkalemia, used to describe an elevated level of potassium in the blood, occurs when there is a disturbance in the balance between intake and elimination or a shift of potassium between the intracellular and extracellular spaces.



Lori Wetmore, PharmD, BCPS

Latest:

Redesigning Heart Failure Management to Optimize Patient and System Outcomes

This article reviews current drug therapies for heart failure and therapy integration into a patient care framework improving patient adherence, quality of life, and decreased risk of readmission to acute care facilities.


Esther Owusu Bediako

Latest:

Geriatric Cancers Present Many Therapeutic Challenges

Pharmacists should develop treatment plans with an active interdisciplinary team and patient involvement.



Edmund J. Pezalla, MD, MPH

Latest:

Hemophilia and Managed Care: Partnering to Achieve Cost-Effective Care

Exploring how health plans and hemophilia treatment centers can better work together to deliver high-quality care and manage costs associated with hemophilia.


Kyle Patterson, PharmD

Latest:

Management of VTE: 10 New Recommendations

Dr. Tafreshi is professor and director of cardiology pharmacy practice residency at Midwestern University College of Pharmacy-Glendale (MWU-CPG), Glendale, Ariz. At the time of submission of this article, Dr. Patterson was a senior pharmacy student at MWU-CPG.


Dimitris Dogramatzis, RPh, PhD

Latest:

Specialty Pharmacy in the European Union

Recent economic developments in Europe have impacted the state of specialty pharmacy. Here is an overview of the fluid situation and a comparison with the United States specialty market.